Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit

Medical Care
Elizabeth A BaylissMarsha A Raebel

Abstract

Medicare Part D beneficiaries who reach the drug benefit threshold (DBT) risk adverse health outcomes. We explore clinical characteristics of beneficiaries who repeatedly reach the DBT during the first 2 years of Medicare Part D and may benefit from proactive identification for medication and care management. Retrospective cohort. 25,320 Medicare Advantage beneficiaries of whom 536 reached the DBT in 2006 only, ("2006 only"); 961 reached the DBT in 2006 and 2007 ("both years"); and 23,823 in neither year. We assessed repeatedly reaching the DBT (relative to 2006 only) as a function of demographics, morbidity (specific conditions and overall burden), medication use (specific classes and overall burden), utilization, and use of catastrophic and/or additional pharmacy benefits. Those who reached the DBT in both years had higher morbidity and utilization. In multivariate analyses, they were more likely than the 2006 only group to have one or more of 5 conditions (chronic pulmonary disease, dementia, depression, incontinence, and Parkinson disease), and within these conditions were more likely to use categories of trade-name medications for which there are limited available generic alternatives. Repeatedly reaching the DBT is a func...Continue Reading

References

Feb 1, 1992·Journal of Clinical Epidemiology·M Von KorffK Saunders
Mar 10, 2001·Medical Care·E R CoxJ L Draugalis
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Chien-Wen TsengCarol M Mangione
Aug 26, 2004·JAMA : the Journal of the American Medical Association·Chien-Wen TsengCarol M Mangione
Jan 20, 2006·Journal of the American Geriatrics Society·John D Piette, Michele Heisler
Jun 2, 2006·The New England Journal of Medicine·John HsuJoseph V Selby
Dec 21, 2006·Journal of the American Pharmacists Association : JAPhA·Daniel R TouchetteJuan C Blackburn
Mar 1, 2007·JAMA : the Journal of the American Medical Association·Scott A BerkowitzGerard F Anderson
Apr 24, 2008·JAMA : the Journal of the American Medical Association·John HsuJoseph P Newhouse
Sep 26, 2008·Medical Care·James M NaessensClaudia R Campbell
Dec 4, 2008·JAMA : the Journal of the American Medical Association·Aaron S KesselheimWilliam H Shrank

❮ Previous
Next ❯

Citations

Jan 11, 2013·Health & Social Work·Pamela J KovacsNorman Carroll
Jan 1, 2011·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Richard C van KleefRené C J A van Vliet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.